Antiviral agents - Strategic Insights Report (Page 2)

Antiviral agents

New Breakthrough in Science: One-Step Stereoselective Synthesis of b-N-benzothiazolyl Glycosides

Researchers at the Institute of Organic Chemistry, Ukraine, have made a groundbreaking discovery in the field of science, developing a one-step stereoselective synthesis of b-N-benzothiazolyl glycosides. The new method involves glycosylation of amino-2-pentafluorosulfanyl-1,3-benzothiazole and amino-2-trifluoromethyl-1,3-benzothiazole derivatives using unprotected d-glucose in ethanol solution. This innovative approach has been confirmed

Antiviral agents

Researchers Discover New Data on RNA Viruses - Influenza A Virus

Researchers at Friedrich-Loeffler-Institut have made a significant breakthrough in understanding how to combat influenza A viruses. According to their research, published in the journal Antiviral Research, combining the antiviral drug N4-hydroxycytidine (NHC) with inhibitors of pyrimidine biosynthesis has shown potent activity against influenza A viruses in both cell cultures and

Antiviral agents

New Study Links X-Linked TLR7 Genotype to Increased Risk of Severe Multisystem Inflammatory Syndrome in Children

Research conducted by the Rene Rachou Institute has found a significant association between the X-linked TLR7 rs179008 T allele and an increased risk of severe multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection. The study, published in the International Journal of Molecular Sciences, analyzed 73 hospitalized children in Brazil

Antiviral agents

Breakthrough in COVID-19 Research: Scientists Discover Potential New Drug and Platform for Finding Medicines Against Infectious Diseases

Scientists at The Wertheim UF Scripps Institute have made a significant breakthrough in the development of a new antiviral drug against COVID-19 and other diseases. A collaboration led by Matthew D. Disney, Ph.D., and his team devised a powerful new platform for finding medicines to fight many types of

Antiviral agents

New Data on COVID-19: Researchers Discover Promising Therapeutic Potential of Zapnometinib

Researchers have made a significant breakthrough in understanding the treatment of severe COVID-19, with a recent study revealing the effectiveness of the MEK inhibitor zapnometinib in reducing viral load and alleviating lung pathology in hospitalized patients. The study, conducted by researchers at Eberhard-Karls University in Tuebingen, Germany, demonstrated that zapnometinib

Antiviral agents

Breakthrough Cryo-EM Structures Expose Multiple Drug Targets in HSV-1 Replication Protein

Researchers from Karolinska Institutet, the University of Gothenburg, and the Centre for Structural Systems Biology in Hamburg have made a groundbreaking discovery in the fight against herpes simplex virus-1 (HSV-1). Using cryo-electron microscopy (cryo-EM), they have captured high-resolution structures of the origin-binding protein (OBP), a critical component of viral DNA

Avian influenza

Genetic Reinstatement of RIG-I in Chickens Provides Insights into Avian Immune Evolution and Influenza Interaction

Scientists at the Technical University Munich (TU Munich) have published a groundbreaking study on the reinstatement of the retinoic acid-inducible gene I (RIG-I) in chickens. This research sheds light on the mechanisms underlying the avian immune system's response to avian influenza (bird flu) and highlights the importance of

Fishes

New Study Reveals Promising Antiviral Agent Against Fish Iridoviruses

Research conducted by scientists from Northwest A&F University has identified a compound called chlorchinaldol as a potent antiviral agent against fish iridoviruses, including the largemouth bass virus (LMBV) and Singapore grouper iridovirus (SGIV). These viruses pose significant threats to aquaculture industries, resulting in substantial economic losses. The study

Influenza

New Insights into Influenza A Virus: Research Suggests Cooperative Action between IFITM Proteins

Researchers at the National Cancer Institute (NCI) have made a significant discovery in understanding the mechanisms behind influenza A virus infection. According to a recent study published in bioRxiv, interferon-induced transmembrane (IFITM) proteins, specifically IFITM1 and IFITM3, work together to restrict virus entry in endolysosomes, providing critical antiviral protection against

Herbal medicine

Antiviral Potential of Plant-Derived Polyphenols Against Varicellovirus Bovinealpha1

Researchers at the University of Novi Sad have evaluated the antiviral potential of five polyphenolic compounds found in medicinal plants against bovine alphaherpesvirus type 1 (BoAHV-1), a model for the Orthoherpesviridae family. The study aimed to assess the cytotoxicity and antiviral activity of quercetin, rutin, baicalein, (-)-epicatechin, and ethyl

Antiviral agents

Mount Sinai Awarded $11.8 Million to Develop Broad-Spectrum Antivirals

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded up to $11.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a new approach to antiviral therapy. The project, called Closing the Doors to All Pathogens Through Integrated Digital Experiments (DOORs), aims

HIV patients

Rapid Initiation of Direct-Acting Antivirals Boosts Hepatitis C Treatment Outcomes in People with HIV

Research published in the International Journal of Antimicrobial Agents has highlighted the significance of rapid initiation of direct-acting antivirals (DAAs) in achieving favorable hepatitis C virus (HCV) treatment outcomes among people with HIV (PWH). A retrospective cohort study conducted at a medical center in Taiwan found that integrating HCV treatment

See all